CTCBio Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 254

Employees

  • Stock Symbol
  • 060590

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $2.08
  • (As of Friday Closing)

CTCBio General Information

Description

CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

Contact Information

Website
www.ctcbio.com
Formerly Known As
World Livestock, Sechuk, Sechuk International
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 509, 12th floor, Dosan-daero
  • Gangnam-gu, Cheongdam-dong
  • Seoul, Gyeonggi-do
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Other Commercial Products
Other Agriculture
Biotechnology
Stock Exchange
KRX
Corporate Office
  • 509, 12th floor, Dosan-daero
  • Gangnam-gu, Cheongdam-dong
  • Seoul, Gyeonggi-do
  • South Korea
+82

CTCBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CTCBio Stock Performance

As of 13-Nov-2026, CTCBio’s stock price is $2.08. Its current market cap is $49.6M with 23.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.08 $1.99 $1.73 - $3.82 $49.6M 23.9M 38.8K $0.22

CTCBio Financials Summary

As of 30-Jun-2026, CTCBio has a trailing 12-month revenue of $90.6M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 58,175 88,213 115,493 205,102
Revenue 90,638 86,969 87,858 105,456
EBITDA 11,793 8,095 2,142 (5,541)
Net Income 5,177 2,277 (3,826) (11,922)
Total Assets 97,356 99,468 104,339 128,707
Total Debt 26,139 26,905 22,315 27,384
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CTCBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CTCBio‘s full profile, request access.

Request a free trial

CTCBio Patents

CTCBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260263361-A1 Cannabidiol aqueous solution composition and cannabidiol-containing pharmaceutical preparation comprising same Pending 17-Mar-2023
WO-2024196096-A1 Cannabidiol aqueous solution composition and cannabidiol-containing pharmaceutical preparation comprising same Inactive 17-Mar-2023
WO-2024136615-A1 Lactobacillus having prophylactic or therapeutic activity for colitis disease and antibacterial activity against harmful gut bacteria and use thereof Inactive 23-Dec-2022
WO-2023080764-A1 Lactic acid bacteria having antibacterial activity against microorganisms causing vaginosis or urinary tract infection and use thereof Inactive 08-Nov-2021
CA-3150011-A1 Intraoral fast disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation Pending 09-Aug-2019 A61K36/3482
To view CTCBio’s complete patent history, request access »

CTCBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CTCBio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CTCBio‘s full profile, request access.

Request a free trial

CTCBio Investments & Acquisitions (2)

CTCBio’s most recent deal was a Corporate Asset Purchase with SK Chemical (Ansan Plant). The deal was made on 01-Sep-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SK Chemical (Ansan Plant) 01-Sep-2014 Corporate Asset Purchase Buildings and Property
LG Life Sciences (Animal Drug Business) 01-Apr-2007 Merger/Acquisition Other Agriculture
To view CTCBio’s complete investments and acquisitions history, request access »

CTCBio ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view CTCBio’s complete esg history, request access »

CTCBio FAQs

  • When was CTCBio founded?

    CTCBio was founded in 1993.

  • Where is CTCBio headquartered?

    CTCBio is headquartered in Seoul, South Korea.

  • What is the size of CTCBio?

    CTCBio has 254 total employees.

  • What industry is CTCBio in?

    CTCBio’s primary industry is Pharmaceuticals.

  • Is CTCBio a private or public company?

    CTCBio is a Public company.

  • What is CTCBio’s stock symbol?

    The ticker symbol for CTCBio is 060590.

  • What is the current stock price of CTCBio?

    As of 13-Nov-2026 the stock price of CTCBio is $2.08.

  • What is the current market cap of CTCBio?

    The current market capitalization of CTCBio is $49.6M.

  • What is CTCBio’s current revenue?

    The trailing twelve month revenue for CTCBio is $90.6M.

  • What is CTCBio’s annual earnings per share (EPS)?

    CTCBio’s EPS for 12 months was $0.22.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process